The present invention relates to sulfones that are useful in the treatment of chemokine-mediated disorders. In certain embodiments, the present invention concerns the compounds that are MCP-1 receptor antagonists.
本发明涉及用于治疗
趋化因子介导的疾病的磺酮。在某些实施例中,本发明涉及MCP-1受体拮抗剂化合物。